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Following short-term culture, Langerhans cells mature
morphologically and functionally into potent immunosti-
mulatory cells. As regulation of gene expression accom-
panies thismaturation process, it is likely that differentially
expressed genes are involved in the maturation events.
Using the recentlydescribedmethodofdifferential display,
we generated cDNA expression patterns starting with
mRNA of murine epidermal Langerhans cells isolated
eitherdirectly (fLC)or following3dcultivation (cLC).Five
hundredputativedifferentially expressed cDNAfragments
were recovered from the gel. For a part of the fragments
differential expression was confirmed by dot blot and
Southern hybridization procedures. These cDNA frag-
Dendritic cells (DC) are characterized by their uniquepotential to initiate a specific immune response bystimulating naı¨ve T cells. The molecular basis ofthis unique ability has not yet been fully clarified.Langerhans cells, the DC resident in the epidermis,
are especially suited to study this aspect of DC function (Stingl et al,
1989). Epidermal Langerhans cells represent an immature population
of DC as indicated by their low expression of co-stimulatory molecules
and their inability to stimulate naı¨ve T cells (Inaba et al, 1986).
Following contact with antigen, Langerhans cells migrate via the lymph
to the draining lymph nodes, where they present antigen-major
histocompatibility complexes (MHC) to specific T cells resulting in
primary activation of the latter. During the migration phase, Langerhans
cells undergo substantial structural and functional alterations related to
antigen uptake, antigen processing, co-stimulatory capacity, and
dendritic morphology (Steinman et al, 1995). The maturation process
of Langerhans cells can be simulated in vitro by short-term cultivation
of epidermal cell suspensions (Schuler and Steinman, 1985). During
this cultivation period, keratinocytes supply the factors essential for
survival and maturation of the co-cultured Langerhans cells, including
granulocyte-macrophage colony stimulating factor (Heufler et al, 1988).
Comparing the mRNA expression of freshly isolated Langerhans
cells (fLC) to that of cultured Langerhans cells (cLC) is a suitable
system to detect genes involved in maturation of DC. fLC and cLC
are expected to have the housekeeping genes as well as Langerhans
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ments were subcloned and sequenced following the veri-
fication step. Database searches revealed that unknown
genesaswell asalreadycharacterizedgeneswere identified.
A cDNA fragment preferentially hybridizing with fLC was
identified as the murine surface marker 4F2 (CD98).
Downregulation of the activation marker 4F2/CD98 was
confirmed by additional analysis at the mRNA and protein
level. The downregulation of 4F2 surface expression on
cLC is compatible with the notion that the committed,
terminally differentiated cLC downregulate proteins
involved in proliferation and cell survival. Key words: differ-
ential gene expression/epidermal cells/JNK2/skin. J Invest
Dermatol 110:57–61, 1998
cell-specific genes in common; however, they should differ in the
expression of genes involved specifically in the maturation process.
Such genes can be identified by differential display (Liang and Pardee,
1992). By this method it is possible to generate reproducible cDNA
expression patterns of two cell populations and to detect cDNA
fragments yielding differential signals.
By applying differential display methodology to fLC and cLC, we
isolated the activation marker 4F2 (CD98). The differential expression
of CD98 was further analyzed on the mRNA and protein level.
MATERIALS AND METHODS
Animals BALB/C Ann and C57BL/6 mice were bred in our animal
facilities from breeding pairs originally obtained from the Zentralinstitut fu¨r
Versuchstierkunde (Hannover, Germany). The mice were used at 2–5 mo of age.
Antibodies Monoclonal antibodies (MoAb) specific for 4F2/CD98 (H202–
141, rat IgG2a, phycoerythrin-labeled) and mouse I-Ad [AMS, mouse IgG2b,
fluoroscein isothiocyanate (FITC)-labeled], as well as rat IgG2a isotype control
MoAb (R-35–95, phycoerythrin-labeled), were supplied by Pharmingen (San
Diego, CA). FITC-labeled mouse IgG2b isotype control MoAb 104–02 was
purchased from Southern Biotechnology (Birmingham, LA) and polyvalent
goat anti-mouse or rat IgG antibodies were purchased from Sigma (Deisenhofen,
Germany). Clone 2G9 (anti-I-Ad, rat IgG2a) (Becker et al, 1992) was kindly given
to us by Dr. M. Mohamadzadeh (Universita¨ts-Hautklinik, Mainz, Germany).
Preparation and short-term in vitro culture of epidermal cells Epidermal
cell suspensions were prepared from pelts as described previously (Becker et al,
1991); and 6–8 3 107 cells (viability .85%) were obtained per mouse. The
epidermal cell suspension was either used directly or cultivated for 1–3 d
(Weigmann et al, 1997). Langerhans cells were enriched from epidermal cells
by immunomagnetic separation with Dynabeads M-450 (Dynal, Hamburg,
Germany) (Hanau et al, 1988) coupled with goat anti-rat IgG and 2G9 antibodies
as described (Weigmann et al, 1997). A purity of Langerhans cells (viability
ù95%) of µ92–95% was obtained as determined by the ratio of rosetted to
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Figure 1. Functional characterization of fLC and cLC. (A) fLC derived
from BALB/C mice that had been purified by paramagnetic separation (purity
94%) were co-cultured in the numbers indicated with 5 3 104 T hybridoma
cells 3DO-54.8 in the presence or absence of 1 mg ovalbumin per ml. After
20 h the activation of 3DO-54.8 cells was estimated by measurement of the
interleukin-3 produced. Fifty microliters supernatants were removed and
cultivated with 103 SN1.B3 indicator cells for 36 h. [3H]Thymidine (5.6 kBq)
was present during the last 12 h of culture. Data represent mean cpm of
triplicate cultures 6 SD. Supernatants of 3DO-54.8 cells, of fLC alone, or of
fLC co-cultured with 3DO-54.8 cells without ovalbumin added yielded induced
proliferation of SN1.B3 cells below 800 cpm. The experiment shown is
representative of five experiments. (B) fLC (s, purity 82%) and cLC (d, purity
85%) derived from BALB/C mice were co-cultured in the indicated cell
numbers with 3 3 105 nylon-wool enriched allogeneic C57BL/6 T cells for
96 h. [3H]Thymidine (28 kBq) was present during the last 12 h of culture.
Data represent mean cpm of triplicate cultures 6 SD. fLC, cLC, or T cells
yielded cpm below 200. The experiment shown is representative of five
experiments.
nonrosetted cells. The non-Langerhans cells population consists mainly of
keratinocytes with a few dendritic epidermal T cells.
T cell stimulation assays T cell stimulation assays were carried out in 96
well flat-bottom Costar plates (Technomara, Fernwald, Germany) in a final
volume of 200 µl of Iscove’s modified Dulbecco’s medium (Life Technologies,
Eggenstein, Germany), supplemented with 5% fetal calf serum, 2 mM L-
glutamine, 100 IU penicillin, 100 µg streptomycin per ml, and 5 3 10–5 M 2-
mercaptoethanol. 3DO-54.8 hybridoma cells (5 3 104) (Shimonkevitz et al,
1983), a kind gift of Dr. Ph. Marrack (National Jewish Center for Immunology
Figure 2. Differential display of fLC and cLC cultivated for 3 d. mRNA
derived from fLC (d0) and cLC (d3) was reverse transcribed with specific oligo
dT-primers and amplified after addition of randomly selected decamer-primers
by PCR (30 cycles). Product amounts were estimated by densitometrical
measurements of ethidium bromide-stained agarose gels, and comparable
amounts were reamplified after addition of 10 µCi [α-32P] dCTP and separated
on a 5% denaturing polyacrylamide gel. Primer combinations: 1, T11C/Dec I;
2, T11G/Dec 1; 3, T11C/Dec 2; 4, T11G/Dec 2.
and Respiratory Medicine, Denver, CO), were stimulated in the presence or
absence of 1 mg ovalbumin per ml presented by freshly prepared or cultured
Langerhans cells at titrated cell numbers as indicated. Indomethacine (1 mg per
ml, Sigma) was added to inhibit the effects of prostaglandins produced by the
few residual keratinocytes. Activation of the 3DO-54.8 cells was estimated after
20 h by measurement of the interleukin-3 produced. Fifty microliters supernatant
was added to 1 3 103 per 50 µl SN1.B3 cells (Schmitt et al, 1987), followed
by 36 h of incubation. Proliferation was measured by incorporation of
[3H]thymidine (5.6 kBq, Amersham Buchler, Braunschweig, Germany) into
cellular DNA during the last 12 h of the culture period, followed by processing
for liquid scintillation counting. Results are expressed as mean cpm 6 SD of
triplicate cultures. For mixed epidermal cell lymphocyte reactions, 3 3 105
nylon wool-enriched (Julius et al, 1973) splenic C57BL/6 T cells were stimulated
with titrated numbers of allogeneic fLC or cLC of BALB/C origin. T cell
proliferation was measured by incorporation of 28 kBq [3H]thymidine into
cellular DNA for 12 h after 84 h of incubation.
Primers The following primers were generated by MWG-Biotech (Ebersberg,
Germany): primers act/1 (GTG GGC CGC TCT AGG CAC CA) and act/2
(TAG CCC TCG TAG ATG GGC ACA G) were chosen to amplify a 403-
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Figure 3. Verification of differential expression of cDNA during
maturation of Langerhans cells. Sandwich blots of reamplified differential
display fragments separated on 1.4% agarose gels were hybridized with fLC
(d0)- or cLC (d3)-derived probes. 1, Fragment representing part of the 4F2
heavy chain (CD98) cDNA; 2, fragment representing part of the c-jun N-
terminal kinase 2 (JNK2) cDNA.
bp fragment of murine β-actin cDNA; the primers 4F2–1 (GAG TTC TTG
GCT GCA GGA CG) and 4F2–2 (TCT GCG AGG AGT CCT GCT TG)
amplify a 326-bp product of the murine 4F2 heavy chain; for generation of
competitive standard molecules the primers 4F2St/1 (CTT GGC TGC AGG
ACG TGG GCC GCT CTA G) and 4F2St/2 (GAG GAG TGC TGC TTG
GTA GAT GGG CAC AG) were used; differential display was performed
with the randomly selected primers Dec 1 (AAGCTTCAGAC), Dec 2
(AAGCTTCGTCA), Dec 3 (AAGCTTGCTGA), Dec 4 (AAGCTTGTCAG),
Dec 5 (TACAACGAGG), Dec 6 (GGTACTAAGG), Dec 7 (CGATGACGGT),
Dec 8 (TGCAGCTCAC), and specific oligo dT-primers T11AC, T11CA,
T11AG, T11CG, AAGCT11C, and AAGCT11G. Uni-Amp™-adaptor-specific
primers were purchased from Clontech Laboratories (Palo Alto, CA) and the
sequencing primers lgh and rgh from GenHunter (Brookline, MA).
mRNA Extraction and reverse transcriptase polymerase chain reaction
(RT-PCR) mRNA was isolated using the Quick Prep™ Micro mRNA
Purification Kit (Pharmacia, Freiburg, Germany) and was resuspended in
diethylpyrocarbonate-treated water. The RNA concentration and quality were
assessed by performing RT-PCR with β-actin-specific primers and subsequent
electrophoresis on nondenaturing vertical 1.4% (wt/vol) agarose gels.
cDNA synthesis and amplification were carried out as described (Ross et al,
1995) in a 480 Thermal Cycler (Perkin Elmer Cetus, Ueberlingen, Germany).
For quantitative analysis of the polymerase chain reactions (PCR), equal
amounts of competitor fragments were added to each PCR reaction. The
competitor fragment (435 bp) was constructed according to a method we
described previously (Ross et al, 1995). It is flanked by the primer binding sites
for 4F2–1 and 4F2–2, but has no further sequence homology to the 4F2
heavy chain.
Differential display The differential display was performed according to
Liang and Pardee (1992) with slight modifications (Ross et al, 1997a, b). The
mRNA was prepared using the Quick Prep™ Micro mRNA Purification Kit
(Pharmacia). DNA contaminations were removed by 10 min digestion with
RNase-free DNA (Boehringer, Mannheim, Germany) followed by phenol
extraction and ethanol precipitation of the mRNA. The mRNA was reverse
transcribed using the specific T11 primers. One of the randomly selected
decamer primers was added and the amplification was carried out as described
above with annealing temperature between 37°C and 40°C. Successful ampli-
fication was monitored by agarose gel electrophoresis following 30 cycles of
PCR. Similar amounts of products as estimated by densitometrical measurements
of the ethidium bromide-stained agarose gels were subjected to reamplification
after addition of 10 µCi [α-32P] dCTP and aliquots were separated on 5%
denaturing polyacrylamide gels and detected by autoradiography. Differentially
amplified fragments were recovered from the gel as reported by Bauer et al
(1994) and reamplified with Pfu-DNA-polymerase (Stratagene, Heidelberg,
Germany). Verified differentially expressed cDNA were cloned in Escherichia
coli RR I using the vector pCR-Trap (GenHunter), and sequenced with rgh
and lgh primers (GenHunter) using the T7 Polymerase Sequencing Kit™
(Pharmacia).
Differential screening of isolated cDNA fragments The screening probes
for hybridization were prepared as described (Ross et al, 1997a). Briefly, mRNA
Figure 4. Competitive RT-PCR of the 4F2 heavy chain. Top: localization
of the differential display-derived fragment and of the fragment amplified by
RT-PCR within the 4F2 heavy chain cDNA (1728 bp). The coding region is
boxed. The positions of the amplified fragments are indicated in basepairs
below. (A) For competitive RT-PCR serial dilutions of reverse transcriptase
reactions from fLC (d0) and cLC cultivated for 1 d (d1), 2 d (d2), or 3 d (d3)
were used. The standard molecules were added in equal amounts to each
reaction. Following 29 cycles with decreasing annealing temperatures (2367°C,
2366°C, 25365°C), aliquots of the products were separated on 1.4% agarose
gels. Upper bands, co-amplified standard molecules; lower bands, cDNA-derived
fragments from reverse transcriptase reactions diluted 2-fold from lane to lane
(from left to right); marker, jX 174 3 Hae III. (B) The amount of mRNA for
the 4F2-PCR shown in (A) was standardized by β-actin RT-PCR of fLC (d0)
and cLC cultivated for 1 d (d1), 2 d (d2), or 3 d (d3). Following 29 cycles
with decreasing annealing temperatures (2369°C, 2368°C, 25367°C), aliquots
of the products were separated on 1.4% agarose gels. Marker, jX 174 3 Hae III.
of µ106 fLC or cLC was extracted, reverse transcribed, and ligated with Uni-
Amp™-adaptors (Clontech Laboratories). Aliquots were amplified by PCR
with adaptor-specific primers. The probes were radiolabeled (Feinberg and
Vogelstein, 1983) using the Multiprime™ DNA Labeling System (Amersham)
and subjected to Southern hybridization with replica-filters of the same gel
prepared by sandwich blotting (Maniatis et al, 1982) or with replica-filters
prepared by dot blotting (Ross et al, 1997a).
Fluorescence analysis Langerhans cells were enriched from an epidermal
cell suspension by an indirect panning procedure (Wysocki and Sato, 1978)
using the MoAb 2G9 (Becker et al, 1991). Cells were washed twice in
phosphate-buffered saline (PBS)/2% fetal calf serum per 10 mM sodium azide
and aliquots of 106 cells were incubated with phycoerythrin-labeled rat anti-
4F2 MoAb H202–141 and FITC-labeled mouse anti-I-Ad MoAb (10 µg per
ml each), or for control with phycoerythrin-labeled rat IgG2a MoAb R-35–
95 and FITC-labeled mouse IgG2b MoAb 104–02 (10 µg per ml each) in
50 µl PBS/2% fetal calf serum/10 mM sodium azide. After 45 min the cells
were washed three times in PBS/2% fetal calf serum/10 mM sodium azide and
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Figure 5. Cell surface expression of the 4F2 heavy chain is downregulated
during maturation of Langerhans cells. Cytofluorometrical measurement
of the 4F2 heavy chain surface expression on gated highly MHC class II-
positive fLC (d0) and cLC (d3) was performed as stated in Materials and Methods.
Heavy line, MoAb H202–141 (anti-4F2); light line, isotype control.
were stored in PBS with 0.7% (wt/vol) paraformaldehyde at 4°C. Cells were
analyzed with a FACScan (Becton-Dickinson, Heidelberg, Germany). Highly
class II-positive cells were gated and analyzed for 4F2 expression.
RESULTS
Characterization of the fLC and cLC population used for
differential display Before starting with the differential display
analysis it was necessary to verify that the isolated fLC and cLC met
the functional criteria described for the two cell populations in the
literature. Therefore we investigated the capacity of fLC derived from
BALB/C mice (H-2d) to process ovalbumin and to stimulate the T-
cell hybridoma 3DO-54.8, which recognizes ovalbumin in the context
of I-Ad. fLC turned out to be efficient antigen presenting cells for
3DO-54.8 cells (Fig 1A). In addition, cLC but not fLC derived from
BALB/C mice were efficient stimulator cells for nylon wool-enriched
allogeneic T cells from C57BL/6 mice (H-2b) (Fig 1B). Furthermore,
cLC showed enhanced surface expression of the co-stimulatory molec-
ules B7–1, B7–2, ICAM-1, and LFA-3 as compared with fLC (data
not shown). In agreement with earlier findings (Teunissen et al, 1990;
Neiss and Reske, 1994), mRNA expression of ICAM-1 was upregulated
in cLC, whereas mRNA expression of MHC class II was downregulated
(data not shown).
Differential display indicates that maturation of Langerhans
cells in vitro is accompanied by differential gene
expression Differential display reactions yielded cDNA expression
patterns with µ50–130 detectable fragments per lane. The cDNA
expression patterns were reproducible for the same primer combination
and the same source of mRNA even when independent cell preparations
or independent mRNA isolates were used. Other decamer primers
and other oligo dT-primers, respectively, yielded completely different
expression patterns, indicating sequence-dependent banding patterns
that were equally dependent on the decamer primer and on the oligo
dT-primer used (Fig 2). fLC and cLC exhibited similar expression
patterns when the same primer combination was used. Approximately
2–10% of the fragments showed differential signals. Signals in the low
molecular weight range (,100 bp) were not taken into account
because the frequency of artificial differences is very high in this
molecular weight range (Liang and Pardee, 1992). To decrease the
number of false positive fragments differential display reactions with
the same primer, combinations were carried out with fLC and cLC
cultivated for 1, 2, and 3 d. Fragments showing either a sustained
increase or a sustained decrease in intensity during cultivation were
selected. Approximately 500 fragments were cut out of the gels.
Selective expression of part of the fragments was verified by differential
hybridization of dot blots as we described previously (Ross et al,
1997b). cDNA fragments that had yielded differential signals on
dot blots following hybridization with cDNA from cLC and fLC,
respectively, were separated on agarose gels. Replica-filters of the same
gel, generated by sandwich blotting, were hybridized with cDNA from
either fLC or cLC. Strong signals with only one of the probes
confirmed the results of differential display and dot blotting. An
example of fragments yielding differential signals on Southern blots is
shown in Fig 3.
Cloning and sequence analysis of the differentially expressed
fragments For reamplification and cloning of the differential display
fragments, the heat-stable Pfu DNA polymerase was used instead of
Taq DNA polymerase in order to ensure that the amplified fragments
were blunt ended for the subsequent cloning procedure into the vector
pCR-Trap. This vector allows positive selection. Only bacteria with
recombinant plasmids are tetracyclin-insensitive. All colonies growing
on tetracyclin-containing agar plates proved to contain recombinant
plasmids. The recombinant clones were sequenced with the vector
specific primers rgh and lgh. Homology searches of the sequences
with the EMBL-database entries (geall database, DKFZ, Heidelberg,
Germany) were performed.
One of the cDNA fragments preferentially expressed in fLC (Fig 3,
panel 1) represented part of the coding region of the murine 4F2 heavy
chain (CD98) (accession number: X14309; pos. 1299–1564). Another
fragment (Fig 3, panel 2) showed 88.9%/82.5% sequence homology
to the rat/human JNK2 cDNA (accession number: RNSAPKA, rat/
HSJNK, human). Other cDNA, with decreased or enhanced expression
in cLC, showed limited homology to uncharacterized, partially
sequenced human cDNA, indicating that not yet characterized cDNA
had been isolated.
Verification of the differential expression of 4F2 in fLC and cLC
by competitive RT-PCR We decided to further analyze the
expression of 4F2 in fLC and cLC by RT-PCR to confirm the results
from differential display. 4F2 was selected for further investigations as
it is a surface molecule, a monoclonal antibody is available, the function
is already characterized, and its downregulation on cLC seems to be
reasonable in the light of Langerhans cells function. Primers were
chosen to amplify a 326-bp product of the coding region of the 4F2
heavy chain not overlapping with the differential display fragment in
order to exclude that the differential display fragment was derived from
a 4F2-homologous region of a so far unknown gene. The position of
the fragment amplified by RT-PCR using the primers 4F2–1 and 4F2–
2 within the 4F2 heavy chain cDNA and the position of the cDNA
fragment isolated by differential display is shown in Fig 4.
For quantitation of RT-PCR we constructed competitive standard
molecules according to a method we published previously (Ross et al,
1995). The standard molecules are flanked by the primer binding sites
for 4F2–1 and 4F2–2 and therefore can be amplified with the same
primers as used for amplification of the 4F2 heavy chain, but they
have no internal homology to the nucleotide sequence of the 4F2
heavy chain. Equal amounts of the competitor fragments were added
to serial dilutions of reverse transcriptase reactions and were co-
amplified by PCR. Competitor fragments and cDNA-derived fragments
are distinguishable in size following gel electrophoresis. Similar signal
intensities of the competitor-derived products in all reactions indicated
that the PCR worked with comparable efficiency. Parallel reactions
with mRNA derived from fLC and Langerhans cells cultivated for 1,
2, and 3 d show that the mRNA expression of the 4F2 heavy chain
was downregulated during maturation (Fig 4A). The quality and
amount of mRNA was monitored by β-actin RT-PCR (Fig 4B).
Downregulation of 4F2 surface expression In order to analyze
4F2 expression on Langerhans cells at the protein level we performed
cytofluorometrical measurements with fLC and cLC using the MoAb
H202–141. Compared with the isotype controls, 4F2 surface expression
on gated MHC class II-positive Langerhans cells decreased markedly
during cultivation in agreement with the mRNA data obtained (Fig 5).
DISCUSSION
In this report we show that the gene coding for the 4F2 (CD98) heavy
chain is downregulated during in vitro maturation of Langerhans cells.
This was shown by applying differential display reactions to generate
cDNA expression patterns of fLC and cLC, followed by isolation,
cloning, and sequencing of differentially expressed cDNA fragments.
Downregulation at the mRNA level was shown by competitive
RT-PCR, and downregulation at the protein level was shown by
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cytofluorometrical measurement of the surface expression of the 4F2
heavy chain. Although Langerhans cells used for competitive RT-PCR
were highly purified, it cannot be excluded that the differential
signals observed were due to different contributions of mRNA from
contaminating cells, mainly keratinocytes, especially because it is known
that keratinocytes express 4F2 (Fernandez-Herrera et al, 1989). This
possibility is ruled out by the cytofluorometric analysis. Langerhans
cells represent the only MHC class II-positive cell population of the
murine epidermis, and cells with high MHC class II expression were
gated for this analysis. Moreover, keratinocytes showed only moderate
expression of the 4F2 heavy chain (not shown).
Differential expression of the surface marker 4F2 is reasonable in
the light of Langerhans cell function. 4F2 is known to be involved in
cell survival and 4F2 is highly expressed on nearly all tumor cells, on
immortalized cell lines, and on proliferating cells exhibiting especially
high expression levels during mitosis (Parmacek et al, 1989). The
protein was reported to be involved in the control of intracellular
Ca21 levels (Michalak et al, 1986), and recent data provide evidence
that 4F2 is an amino acid transporter (Wells et al, 1992). Downregulation
of the activation marker 4F2 may be involved in the process of
apoptosis of cLC. It is important for the function of the immune
system that the committed, terminally differentiated Langerhans cells
prime naı¨ve T cells in the draining lymph nodes just for a limited
period of time and then undergo apoptosis. Downregulation of proteins
necessary for cell survival such as 4F2 may be involved in this process.
Like the 4F2 heavy chain, JNK2 has not been reported before to
be expressed in Langerhans cells. Its expression in Langerhans cells and
its expression levels during maturation of Langerhans cells have to be
analyzed in anology with the data presented for the 4F2 heavy chain.
JNK2 specifically phosphorylates the NH2-terminal activation domain
of the transcription factor c-jun (Sluss et al, 1994) and is efficiently
activated by stress signals such as ultraviolet light and by the pro-
inflammatory cytokines tumor necrosis factor-α and interleukin-1
(Kyriakis et al, 1994; Sluss et al, 1994). As tumor necrosis factor-α is
involved in contact hypersensitivity reactions (Moodycliffe et al, 1994)
and induces Langerhans cells migration from the skin to draining
lymph nodes (Cumberbatch and Kimber, 1992; Kimber and
Cumberbatch, 1992), investigation of the role of JNK2 promises to
provide valuable insights into the regulation of these processes.
Based on our experience with differential display and differential
screening of a cLC-derived cDNA library (data not shown), we roughly
estimate the percentage of differentially expressed genes in fLC and
cLC to be in the range of 1–3%. These differences in gene expression
reflect the substantial alterations Langerhans cells undergo during
maturation, including changes in antigen processing, antigen presenta-
tion, morphology, and migration. It should be emphasized, however,
that fLC and cLC are closely related differentiation stages of a well-
defined cell population, thereby suggesting that differences in gene
expression might be important for the maturation events. It should
therefore be possible to identify at least some of the key players
involved in these processes by differential display and other comparative
approaches on the mRNA level. A combined strategy using differential
display or a related PCR-dependent technique and subtraction libraries
or differential screening of cLC-derived libraries is expected to be most
promising because both approaches should yield different cDNA.
Following statistical considerations, the most abundant differentially
expressed cDNA may be obtained using the method of cDNA-library
screening. On the contrary, weakly expressed genes are likely to be
identified by differential display, because randomly selected primer
sequences exhibiting maximum identity will yield strong signals. Many
cytokines and transcription factor genes belong to this category. The
isolation of the moderately expressed regulatory protein JNK2 supports
this prediction. Furthermore, upregulated as well as downregulated
genes can be isolated by differential display whereas library-based
methods require two independent approaches.
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